Gene Editing Patent Application Trends 2025

Gene Editing patent applications in 2025

Top Technology Areas in Gene Editing

Top CPC Codes

• C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
  • Count: 194 patents
  • Example: 20250113820. CRYOGENICALLY ARRAYABLE STABLE TRANSFECTION (Synthego Corporation)
• C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
  • Count: 184 patents
  • Example: 20250113820. CRYOGENICALLY ARRAYABLE STABLE TRANSFECTION (Synthego Corporation)
• C12N15/11 (DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology,)
  • Count: 106 patents
  • Example: 20250115875. COMPOSITIONS AND METHODS FOR CELL ENGINEERING FOR MEAT PRODUCTION (Fork & Goode, Inc.)
• C12N15/86 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
  • Count: 96 patents
  • Example: 20250114480. GENE THERAPY FOR GENETIC HEARING LOSS (BridgeBio Gene Therapy Research, Inc.)
• C12N2750/14143 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
  • Count: 85 patents
  • Example: 20250114480. GENE THERAPY FOR GENETIC HEARING LOSS (BridgeBio Gene Therapy Research, Inc.)
• C12N15/907 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
  • Count: 73 patents
  • Example: 20250114482. THERAPEUTIC APPLICATIONS OF CPF1-BASED GENOME EDITING (Duke University)
• C12N15/111 ({General methods applicable to biologically active non-coding nucleic acids})
  • Count: 65 patents
  • Example: 20250113820. CRYOGENICALLY ARRAYABLE STABLE TRANSFECTION (Synthego Corporation)
• A61K48/0058 (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy)
  • Count: 39 patents
  • Example: 20250114482. THERAPEUTIC APPLICATIONS OF CPF1-BASED GENOME EDITING (Duke University)
• A61K48/005 (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy)
  • Count: 36 patents
  • Example: 20250114480. GENE THERAPY FOR GENETIC HEARING LOSS (BridgeBio Gene Therapy Research, Inc.)
• C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants)
  • Count: 35 patents
  • Example: 20250114482. THERAPEUTIC APPLICATIONS OF CPF1-BASED GENOME EDITING (Duke University)

Top Companies in Gene Editing 2025

The Regents of the University of California

• Number of Gene Editing patents: 14
• Top CPC codes:
  • C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 10 patents
  • C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 10 patents
  • C12N15/11 (DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology,): 6 patents
• Recent patents:
  • 20250145959. COMPOSITIONS AND METHODS FOR PRODUCING SMOOTH MUSCLE CELLS (The Regents of the University of California) (20250508)
  • 20250145968. GENETIC ENGINEERING OF BACTERIOPHAGES USING CRISPR-CAS13A (The Regents of the University of California) (20250508)
  • 20250101385. GENE EDITING TO IMPROVE PANCREATIC BETA CELL YIELD IN DIRECTED DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS (The Regents of the University of California) (20250327)

SHENZHEN METALENX TECHNOLOGY CO.,LTD

• Number of Gene Editing patents: 13
• Top CPC codes:
  • G02B1/002 (Optical elements characterised by the material of which they are made; Optical coatings for optical elements): 6 patents
  • G02B2207/101 (OPTICAL ELEMENTS, SYSTEMS OR APPARATUS): 5 patents
  • G02B13/0055 ({employing a special optical element}): 4 patents
• Recent patents:
  • 20250123466. HYBRID LENS AND OPTICAL SYSTEM (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20250417)
  • 20250123468. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20250417)
  • 20250123469. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20250417)

THE BROAD INSTITUTE, INC.

• Number of Gene Editing patents: 6
• Top CPC codes:
  • C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 5 patents
  • C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 5 patents
  • C12N15/907 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
• Recent patents:
  • 20250171756. NOVEL TYPE VI CRISPR ENZYMES AND SYSTEMS (THE BROAD INSTITUTE, INC.) (20250529)
  • 20250171811. TYPE I-B CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS (THE BROAD INSTITUTE, INC.) (20250529)
  • 20250099623. COMPOSITIONS AND METHODS FOR ENHANCING INTRA-MITOCHONDRIAL PROTEIN TRANSLATION AND OXIDATIVE PHOSPHORYLATION (THE BROAD INSTITUTE, INC.) (20250327)

PIONEER HI-BRED INTERNATIONAL, INC.

• Number of Gene Editing patents: 6
• Top CPC codes:
  • C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 5 patents
  • C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 5 patents
  • C12N15/8213 ({Targeted insertion of genes into the plant genome by homologous recombination}): 3 patents
• Recent patents:
  • 20250122513. GENERATION OF SITE SPECIFIC INTEGRATION SITES FOR COMPLEX TRAIT LOCI IN CORN AND SOYBEAN, AND METHODS OF USE (PIONEER HI-BRED INTERNATIONAL, INC.) (20250417)
  • 20250122536. NOVEL CAS9 ORTHOLOGS (PIONEER HI-BRED INTERNATIONAL, INC.) (20250417)
  • 20250011804. INTERACTORS AND TARGETS FOR IMPROVING PLANT AGRONOMIC CHARACTERISTICS (PIONEER HI-BRED INTERNATIONAL, INC.) (20250109)

The Trustees of Columbia University in the City of New York

• Number of Gene Editing patents: 5
• Top CPC codes:
  • C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
  • C12N15/11 (DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology,): 3 patents
  • C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
• Recent patents:
  • 20250171810. COMPOSITIONS, SYSTEMS, AND METHODS FOR PRIME EDITING (The Trustees of Columbia University in the City of New York) (20250529)
  • 20250163410. CRISPR-TRANSPOSON SYSTEMS FOR DNA MODIFICATION (The Trustees of Columbia University in the City of New York) (20250522)
  • 20250098652. Genetic Modifications for Xenotransplantation (The Trustees of Columbia University in the City of New York) (20250327)

Tune Therapeutics, Inc.

• Number of Gene Editing patents: 5
• Top CPC codes:
  • C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 5 patents
  • C12N15/11 (DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology,): 5 patents
  • C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 5 patents
• Recent patents:
  • 20250136989. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.) (20250501)
  • 20250171782. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.) (20250529)
  • 20250154503. COMPOSITIONS, SYSTEMS, AND METHODS FOR PROGRAMMING T CELL PHENOTYPES THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.) (20250515)

The Broad Institute, Inc.

• Number of Gene Editing patents: 5
• Top CPC codes:
  • C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 5 patents
  • C12N15/111 ({General methods applicable to biologically active non-coding nucleic acids}): 3 patents
  • C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
• Recent patents:
  • 20250101400. NOVEL CRISPR ENZYMES AND SYSTEMS (The Broad Institute, Inc.) (20250327)
  • 20250101468. DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY (The Broad Institute, Inc.) (20250327)
  • 20250101500. AMPLIFICATION ASSAYS USING CRISPR-CAS BASED DETECTION (The Broad Institute, Inc.) (20250327)

CRISPR THERAPEUTICS AG

• Number of Gene Editing patents: 5
• Top CPC codes:
  • C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 5 patents
  • C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 4 patents
  • A61K9/5123 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 3 patents
• Recent patents:
  • 20250145998. COMPOSITIONS AND METHODS FOR GENE EDITING BY TARGETING TRANSFERRIN (CRISPR THERAPEUTICS AG) (20250508)
  • 20250011771. METHODS AND COMPOSITIONS FOR TREATING LIPOPROTEIN-RELATED DISEASES (CRISPR THERAPEUTICS AG) (20250109)
  • 20250101439. MATERIALS AND METHODS FOR CONTROLLING GENE EDITING (CRISPR THERAPEUTICS AG) (20250327)

The Trustees of the University of Pennsylvania

• Number of Gene Editing patents: 4
• Top CPC codes:
  • C12N15/86 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
  • C12N2750/14143 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
  • A61K48/0075 (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy): 2 patents
• Recent patents:
  • 20250161493. COMPOSITIONS AND METHODS FOR IN VIVO NUCLEASE-MEDIATED TREATMENT OF ORNITHINE TRANSCARBAMYLASE (OTC) DEFICIENCY (The Trustees of the University of Pennsylvania) (20250522)
  • 20250027900. pH Sensing Technique Based On Graphene Electrodes (The Trustees of the University of Pennsylvania) (20250123)
  • 20250049949. GENE THERAPY FOR LAMIN A-ASSOCIATED DEFICIENCIES (The Trustees of the University of Pennsylvania) (20250213)

Illumina, Inc.

• Number of Gene Editing patents: 4
• Top CPC codes:
  • G06T7/0014 ({using an image reference approach}): 2 patents
  • G06T7/0012 ({Biomedical image inspection}): 2 patents
  • G06T7/246 (using feature-based methods, e.g. the tracking of corners or segments): 2 patents
• Recent patents:
  • 20250166733. DETERMINING STRUCTURAL VARIANTS (Illumina, Inc.) (20250522)
  • 20250148603. CREATING A TEMPLATE OF NUCLEIC ACID SITE LOCATIONS ON A FLOW CELL (Illumina, Inc.) (20250508)
  • 20250148604. ANALYZING IMAGE DATA FROM NUCLEIC ACID SEQUENCING (Illumina, Inc.) (20250508)

New Companies in Gene Editing (Last Month)

File:New Companies in Gene Editing Last Month.png

No new companies detected in the last month.

Emerging Technology Areas in Gene Editing

• C12Y302/0101 (ENZYMES)
  • Count: 1 patents
  • Example: 20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)
• C12Y301/03024 (ENZYMES)
  • Count: 1 patents
  • Example: 20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)
• C12Y301/0301 (ENZYMES)
  • Count: 1 patents
  • Example: 20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)
• C12Y301/03009 (ENZYMES)
  • Count: 1 patents
  • Example: 20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)
• C12Y207/07027 (ENZYMES)
  • Count: 1 patents
  • Example: 20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)
• C12Y207/07009 (ENZYMES)
  • Count: 1 patents
  • Example: 20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)
• C12Y207/01002 (ENZYMES)
  • Count: 1 patents
  • Example: 20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)
• C12Y207/01001 (ENZYMES)
  • Count: 1 patents
  • Example: 20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)
• C12Y204/01014 (ENZYMES)
  • Count: 1 patents
  • Example: 20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)
• C12P19/12 (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer)
  • Count: 1 patents
  • Example: 20250101477. METHOD FOR PRODUCING GLUCOSE AND DERIVATIVES THEREOF BY MEANS OF BIOTRANSFORMATION WITH RECOMBINANT YEAST (SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY)

Top Companies in Emerging Gene Editing Technologies 2025

• SHENZHEN INSTITUTES OF ADVANCEC TECHNOLOGY: 10 patents

Top Inventors in Gene Editing

Chenglong HAO

• Number of Gene Editing patents: 13
• Top companies:
  • SHENZHEN METALENX TECHNOLOGY CO.,LTD: 13 patents
• Recent patents:
  • 20250123466. HYBRID LENS AND OPTICAL SYSTEM (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20250417)
  • 20250123468. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20250417)
  • 20250123469. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20250417)

Fengze TAN

• Number of Gene Editing patents: 13
• Top companies:
  • SHENZHEN METALENX TECHNOLOGY CO.,LTD: 13 patents
• Recent patents:
  • 20250123466. HYBRID LENS AND OPTICAL SYSTEM (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20250417)
  • 20250123468. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20250417)
  • 20250123469. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20250417)

Jian ZHU

• Number of Gene Editing patents: 13
• Top companies:
  • SHENZHEN METALENX TECHNOLOGY CO.,LTD: 13 patents
• Recent patents:
  • 20250123466. HYBRID LENS AND OPTICAL SYSTEM (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20250417)
  • 20250123468. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20250417)
  • 20250123469. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20250417)

Feng Zhang of Cambridge MA (US)

• Number of Gene Editing patents: 5
• Top companies:
  • THE BROAD INSTITUTE, INC.: 4 patents
  • The Broad Institute, Inc.: 1 patents
• Recent patents:
  • 20250171756. NOVEL TYPE VI CRISPR ENZYMES AND SYSTEMS (THE BROAD INSTITUTE, INC.) (20250529)
  • 20250171811. TYPE I-B CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS (THE BROAD INSTITUTE, INC.) (20250529)
  • 20250101400. NOVEL CRISPR ENZYMES AND SYSTEMS (The Broad Institute, Inc.) (20250327)

JOSHUA K. YOUNG of JOHNSTON IA (US)

• Number of Gene Editing patents: 4
• Top companies:
  • PIONEER HI-BRED INTERNATIONAL, INC.: 4 patents
• Recent patents:
  • 20250163393. METHODS AND COMPOSITIONS FOR ADVANCED BREEDING THROUGH TARGETED CHROMOSOME ENGINEERING (PIONEER HI-BRED INTERNATIONAL, INC.) (20250522)
  • 20250027097. HIGH EFFICIENCY LARGE SCALE CHROMOSOMAL GENOME MANIPULATION (PIONEER HI-BRED INTERNATIONAL, INC.) (20250123)
  • 20250122536. NOVEL CAS9 ORTHOLOGS (PIONEER HI-BRED INTERNATIONAL, INC.) (20250417)

Chris RAMSBORG of Seattle WA (US)

• Number of Gene Editing patents: 4
• Top companies:
  • Juno Therapeutics, Inc.: 4 patents
• Recent patents:
  • 20250161450. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.) (20250522)
  • 20250152712. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.) (20250515)
  • 20250121062. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.) (20250417)

Mark L. BONYHADI of Sammamish WA (US)

• Number of Gene Editing patents: 4
• Top companies:
  • Juno Therapeutics, Inc.: 4 patents
• Recent patents:
  • 20250161450. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.) (20250522)
  • 20250152712. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.) (20250515)
  • 20250121062. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.) (20250417)

Calvin CHAN of Seattle WA (US)

• Number of Gene Editing patents: 4
• Top companies:
  • Juno Therapeutics, Inc.: 4 patents
• Recent patents:
  • 20250161450. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.) (20250522)
  • 20250152712. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.) (20250515)
  • 20250121062. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.) (20250417)

Pascal BEAUCHESNE of Seattle WA (US)

• Number of Gene Editing patents: 4
• Top companies:
  • Juno Therapeutics, Inc.: 4 patents
• Recent patents:
  • 20250161450. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.) (20250522)
  • 20250152712. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.) (20250515)
  • 20250121062. METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY (Juno Therapeutics, Inc.) (20250417)

Alexandra Briner Crawley of Cary NC (US)

• Number of Gene Editing patents: 3
• Top companies:
  • LifeEDIT Therapeutics, Inc.: 2 patents
  • Life Edit Therapeutics, Inc.: 1 patents
• Recent patents:
  • 20250066783. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (LifeEDIT Therapeutics, Inc.) (20250227)
  • 20250043315. RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE (LifeEDIT Therapeutics, Inc.) (20250206)
  • 20250092398. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (Life Edit Therapeutics, Inc.) (20250320)

Tedd D. Elich of Durham NC (US)

• Number of Gene Editing patents: 3
• Top companies:
  • LifeEDIT Therapeutics, Inc.: 2 patents
  • Life Edit Therapeutics, Inc.: 1 patents
• Recent patents:
  • 20250066783. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (LifeEDIT Therapeutics, Inc.) (20250227)
  • 20250043315. RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE (LifeEDIT Therapeutics, Inc.) (20250206)
  • 20250092398. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (Life Edit Therapeutics, Inc.) (20250320)

Brian COSGROVE of Durham NC (US)

• Number of Gene Editing patents: 3
• Top companies:
  • Tune Therapeutics, Inc.: 3 patents
• Recent patents:
  • 20250129369. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.) (20250424)
  • 20250136989. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.) (20250501)
  • 20250171782. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.) (20250529)

Kendra CONGDON of Durham NC (US)

• Number of Gene Editing patents: 3
• Top companies:
  • Tune Therapeutics, Inc.: 3 patents
• Recent patents:
  • 20250129369. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.) (20250424)
  • 20250136989. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.) (20250501)
  • 20250171782. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.) (20250529)

Jason DEAN of Seattle WA (US)

• Number of Gene Editing patents: 3
• Top companies:
  • Tune Therapeutics, Inc.: 3 patents
• Recent patents:
  • 20250129369. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.) (20250424)
  • 20250136989. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.) (20250501)
  • 20250171782. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.) (20250529)

Veronica GOUGH of Durham NC (US)

• Number of Gene Editing patents: 3
• Top companies:
  • Tune Therapeutics, Inc.: 3 patents
• Recent patents:
  • 20250129369. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.) (20250424)
  • 20250136989. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.) (20250501)
  • 20250171782. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.) (20250529)

Joshua B. BLACK of Durham NC (US)

• Number of Gene Editing patents: 3
• Top companies:
  • Tune Therapeutics, Inc.: 3 patents
• Recent patents:
  • 20250129369. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.) (20250424)
  • 20250136989. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.) (20250501)
  • 20250171782. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.) (20250529)

Britta JONES of Durham NC (US)

• Number of Gene Editing patents: 3
• Top companies:
  • Tune Therapeutics, Inc.: 3 patents
• Recent patents:
  • 20250129369. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.) (20250424)
  • 20250136989. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.) (20250501)
  • 20250171782. COMPOSITIONS, SYSTEMS, AND METHODS FOR REGULATION OF HEPATITIS B VIRUS THROUGH TARGETED GENE REPRESSION (Tune Therapeutics, Inc.) (20250529)

Heshan LIN

• Number of Gene Editing patents: 3
• Top companies:
  • SHENZHEN METALENX TECHNOLOGY CO.,LTD: 3 patents
• Recent patents:
  • 20250130399. OPTICAL SYSTEM AND OPTICAL CAMERA (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20250424)
  • 20250138162. OPTICAL SYSTEM FOR ToF AND DEPTH CAMERA OF ToF (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20250501)
  • 20250085533. OPTICAL SYSTEM AND OPTICAL CAMERA WORKING AT FAR-INFRARED WAVEBAND (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20250313)

ZHENGLIN HOU of ANKENY IA (US)

• Number of Gene Editing patents: 3
• Top companies:
  • PIONEER HI-BRED INTERNATIONAL, INC.: 3 patents
• Recent patents:
  • 20250075197. ENGINEERED DEAMINASES (PIONEER HI-BRED INTERNATIONAL, INC.) (20250306)
  • 20250122536. NOVEL CAS9 ORTHOLOGS (PIONEER HI-BRED INTERNATIONAL, INC.) (20250417)
  • 20250011804. INTERACTORS AND TARGETS FOR IMPROVING PLANT AGRONOMIC CHARACTERISTICS (PIONEER HI-BRED INTERNATIONAL, INC.) (20250109)

Jonathan Gootenberg of Cambridge MA (US)

• Number of Gene Editing patents: 3
• Top companies:
  • THE BROAD INSTITUTE, INC.: 1 patents
  • Massachusetts Institute of Technology: 1 patents
  • The Broad Institute, Inc.: 1 patents
• Recent patents:
  • 20250075268. CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS (THE BROAD INSTITUTE, INC.) (20250306)
  • 20250092390. SYSTEMS, METHODS, AND COMPOSITIONS FOR SITE-SPECIFIC GENETIC ENGINEERING USING PROGRAMMABLE ADDITION VIA SITE-SPECIFIC TARGETING ELEMENTS (PASTE) (Massachusetts Institute of Technology) (20250320)
  • 20250101400. NOVEL CRISPR ENZYMES AND SYSTEMS (The Broad Institute, Inc.) (20250327)

Shengkan Jin of Belle Mead NJ (US)

• Number of Gene Editing patents: 3
• Top companies:
  • Rutgers, The State University of New Jersey: 3 patents
• Recent patents:
  • 20250171808. Nuclease-Independent Targeted Gene Editing Platform and Uses Thereof (Rutgers, The State University of New Jersey) (20250529)
  • 20250163473. TARGETED GENE EDITING PLATFORM INDEPENDENT OF DNA DOUBLE STRAND BREAK AND USES THEREOF (Rutgers, The State University of New Jersey) (20250522)
  • 20250101464. Nuclease-Independent Targeted Gene Editing Platform and Uses Thereof (Rutgers, The State University of New Jersey) (20250327)

Juan-Carlos Collantes of Princeton NJ (US)

• Number of Gene Editing patents: 3
• Top companies:
  • Rutgers, The State University of New Jersey: 3 patents
• Recent patents:
  • 20250171808. Nuclease-Independent Targeted Gene Editing Platform and Uses Thereof (Rutgers, The State University of New Jersey) (20250529)
  • 20250163473. TARGETED GENE EDITING PLATFORM INDEPENDENT OF DNA DOUBLE STRAND BREAK AND USES THEREOF (Rutgers, The State University of New Jersey) (20250522)
  • 20250101464. Nuclease-Independent Targeted Gene Editing Platform and Uses Thereof (Rutgers, The State University of New Jersey) (20250327)

David R. Liu of Cambridge MA (US)

• Number of Gene Editing patents: 3
• Top companies:
  • The Broad Institute, Inc.: 2 patents
  • President and Fellows of Harvard College: 1 patents
• Recent patents:
  • 20250090687. MITOCHONDRIAL BASE EDITORS AND METHODS FOR EDITING MITOCHONDRIAL DNA (The Broad Institute, Inc.) (20250320)
  • 20250092374. EVOLVED CAS9 PROTEINS FOR GENE EDITING (President and Fellows of Harvard College) (20250320)
  • 20250011748. BASE EDITORS, COMPOSITIONS, AND METHODS FOR MODIFYING THE MITOCHONDRIAL GENOME (The Broad Institute, Inc.) (20250109)

William Douglass WRIGHT of Fairfield CA (US)

• Number of Gene Editing patents: 3
• Top companies:
  • Mammoth Biosciences, Inc.: 3 patents
• Recent patents:
  • 20250154505. EFFECTOR PROTEINS AND METHODS OF USE (Mammoth Biosciences, Inc.) (20250515)
  • 20250145974. ENGINEERED CAS-PHI PROTEINS AND USES THEREOF (Mammoth Biosciences, Inc.) (20250508)
  • 20250101498. EFFECTOR PROTEINS, COMPOSITIONS, SYSTEMS, DEVICES, KITS AND METHODS OF USE THEREOF (Mammoth Biosciences, Inc.) (20250327)

Lucas Benjamin HARRINGTON of San Francisco CA (US)

• Number of Gene Editing patents: 3
• Top companies:
  • Mammoth Biosciences, Inc.: 3 patents
• Recent patents:
  • 20250154505. EFFECTOR PROTEINS AND METHODS OF USE (Mammoth Biosciences, Inc.) (20250515)
  • 20250144246. COMPOSITIONS AND METHODS FOR MODIFYING A HUMAN DYSTROPHIN GENE (Mammoth Biosciences, Inc.) (20250508)
  • 20250145974. ENGINEERED CAS-PHI PROTEINS AND USES THEREOF (Mammoth Biosciences, Inc.) (20250508)

Rui ZHU

• Number of Gene Editing patents: 3
• Top companies:
  • SHENZHEN METALENX TECHNOLOGY CO.,LTD: 3 patents
• Recent patents:
  • 20250123466. HYBRID LENS AND OPTICAL SYSTEM (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20250417)
  • 20250123468. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20250417)
  • 20250123469. OPTICAL SYSTEM AND IMAGING DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20250417)

Clayton BEARD of Durham NC (US)

• Number of Gene Editing patents: 2
• Top companies:
  • BridgeBio Gene Therapy Research, Inc.: 2 patents
• Recent patents:
  • 20250114480. GENE THERAPY FOR GENETIC HEARING LOSS (BridgeBio Gene Therapy Research, Inc.) (20250410)
  • 20250001008. GENE THERAPY FOR GALACTOSEMIA (BridgeBio Gene Therapy Research, Inc.) (20250102)

Charles A. Gersbach of Chapel Hill NC (US)

• Number of Gene Editing patents: 2
• Top companies:
  • Duke University: 2 patents
• Recent patents:
  • 20250114482. THERAPEUTIC APPLICATIONS OF CPF1-BASED GENOME EDITING (Duke University) (20250410)
  • 20250171754. CRISPR-CAS9 COMPOSITIONS AND METHODS WITH A NOVEL CAS9 PROTEIN FOR GENOME EDITING AND GENE REGULATION (Duke University) (20250529)

Tzu-Yao Lin

• Number of Gene Editing patents: 2
• Top companies:
  • GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED: 2 patents
• Recent patents:
  • 20250116761. OPTICAL DEPTH SENSING APPARATUS (GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED) (20250410)
  • 20250164758. IMAGING LENS (GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED) (20250522)

Shih-Chieh Yen

• Number of Gene Editing patents: 2
• Top companies:
  • GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED: 2 patents
• Recent patents:
  • 20250116761. OPTICAL DEPTH SENSING APPARATUS (GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED) (20250410)
  • 20250164758. IMAGING LENS (GUANGZHOU LUXVISIONS INNOVATION TECHNOLOGY LIMITED) (20250522)

Leida Rassouli-Taylor of Philadelphia PA (US)

• Number of Gene Editing patents: 2
• Top companies:
  • Amicus Therapeutics, Inc: 1 patents
  • The Trustees of the University of Pennsylvania: 1 patents
• Recent patents:
  • 20250034533. Compositions And Methods For Treating Mucopolysaccharidosis IIIA (Amicus Therapeutics, Inc) (20250130)
  • 20250041445. GENE THERAPY FOR TREATMENT OF MUCOPOLYSACCHARIDOSIS IIIA (The Trustees of the University of Pennsylvania) (20250206)

Lior IZHAR

• Number of Gene Editing patents: 2
• Top companies:
  • EmendoBio Inc.: 1 patents
  • EMENDOBIO INC: 1 patents
• Recent patents:
  • 20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.) (20250130)
  • [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)

Liat ROCKAH

• Number of Gene Editing patents: 2
• Top companies:
  • EmendoBio Inc.: 1 patents
  • EMENDOBIO INC: 1 patents
• Recent patents:
  • 20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.) (20250130)
  • [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)

Nir HECHT

• Number of Gene Editing patents: 2
• Top companies:
  • EmendoBio Inc.: 1 patents
  • EMENDOBIO INC: 1 patents
• Recent patents:
  • 20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.) (20250130)
  • [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)

Tyson D. Bowen of Morrisville NC (US)

• Number of Gene Editing patents: 2
• Top companies:
  • LifeEDIT Therapeutics, Inc.: 1 patents
  • Life Edit Therapeutics, Inc.: 1 patents
• Recent patents:
  • 20250066783. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (LifeEDIT Therapeutics, Inc.) (20250227)
  • 20250092398. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (Life Edit Therapeutics, Inc.) (20250320)

Mark Moore of Durham NC (US)

• Number of Gene Editing patents: 2
• Top companies:
  • LifeEDIT Therapeutics, Inc.: 1 patents
  • Life Edit Therapeutics, Inc.: 1 patents
• Recent patents:
  • 20250066783. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (LifeEDIT Therapeutics, Inc.) (20250227)
  • 20250092398. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (Life Edit Therapeutics, Inc.) (20250320)

Michael Lassner of Portland OR (US)

• Number of Gene Editing patents: 2
• Top companies:
  • LifeEDIT Therapeutics, Inc.: 1 patents
  • Life Edit Therapeutics, Inc.: 1 patents
• Recent patents:
  • 20250066783. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (LifeEDIT Therapeutics, Inc.) (20250227)
  • 20250092398. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (Life Edit Therapeutics, Inc.) (20250320)

Andrew Garst of Pleasanton CA (US)

• Number of Gene Editing patents: 2
• Top companies:
  • Inscripta, Inc.: 2 patents
• Recent patents:
  • 20250066818. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.) (20250227)
  • 20250075232. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.) (20250306)

Ryan T. Gill of Pleasanton CA (US)

• Number of Gene Editing patents: 2
• Top companies:
  • Inscripta, Inc.: 2 patents
• Recent patents:
  • 20250066818. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.) (20250227)
  • 20250075232. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.) (20250306)

Tanya Elizabeth Warnecke Lipscomb of Pleasanton CA (US)

• Number of Gene Editing patents: 2
• Top companies:
  • Inscripta, Inc.: 2 patents
• Recent patents:
  • 20250066818. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.) (20250227)
  • 20250075232. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.) (20250306)

Cameron Myhrvold of Princeton NJ (US)

• Number of Gene Editing patents: 2
• Top companies:
  • MASSACHUSETTS INSTITUTE OF TECHNOLOGY: 1 patents
  • The Trustees of Princeton University: 1 patents
• Recent patents:
  • 20250066842. SPLIT-LUCIFERASE REPORTER SYSTEMS, COLOR-CODED BEAD MULTIPLEX CRISPR SYSTEMS, AND METHODS OF USE THEREOF IN CRISPR-CAS BASED DIAGNOSTICS (MASSACHUSETTS INSTITUTE OF TECHNOLOGY) (20250227)
  • 20250146089. ABERRANT VIRAL RNA DETECTION USING CAS13 (The Trustees of Princeton University) (20250508)

Eric B. Kmiec of Middletown DE (US)

• Number of Gene Editing patents: 2
• Top companies:
  • Christiana Care Gene Editing Institute, Inc.: 2 patents
• Recent patents:
  • 20250001010. NRAS GENE KNOCKOUT FOR TREATMENT OF CANCER (Christiana Care Gene Editing Institute, Inc.) (20250102)
  • 20250018060. ADENOVIRUS DELIVERY SYSTEM FOR CANCER TREATMENT (Christiana Care Gene Editing Institute, Inc.) (20250116)

Kelly H. Banas of Bear DE (US)

• Number of Gene Editing patents: 2
• Top companies:
  • Christiana Care Gene Editing Institute, Inc.: 2 patents
• Recent patents:
  • 20250001010. NRAS GENE KNOCKOUT FOR TREATMENT OF CANCER (Christiana Care Gene Editing Institute, Inc.) (20250102)
  • 20250018060. ADENOVIRUS DELIVERY SYSTEM FOR CANCER TREATMENT (Christiana Care Gene Editing Institute, Inc.) (20250116)

Joseph J. HIGGINS of Lexington MA (US)

• Number of Gene Editing patents: 2
• Top companies:
  • Saliogen Therapeutics, Inc.: 2 patents
• Recent patents:
  • 20250002876. MOBILE ELEMENTS AND CHIMERIC CONSTRUCTS THEREOF (Saliogen Therapeutics, Inc.) (20250102)
  • 20250011736. TRANSPOSABLE MOBILE ELEMENTS WITH ENHANCED GENOMIC SITE SELECTION (Saliogen Therapeutics, Inc.) (20250109)

Nancy CRAIG of Lexington MA (US)

• Number of Gene Editing patents: 2
• Top companies:
  • Saliogen Therapeutics, Inc.: 2 patents
• Recent patents:
  • 20250002876. MOBILE ELEMENTS AND CHIMERIC CONSTRUCTS THEREOF (Saliogen Therapeutics, Inc.) (20250102)
  • 20250011736. TRANSPOSABLE MOBILE ELEMENTS WITH ENHANCED GENOMIC SITE SELECTION (Saliogen Therapeutics, Inc.) (20250109)

Christopher BROWN of Albany CA (US)

• Number of Gene Editing patents: 2
• Top companies:
  • Metagenomi, Inc.: 1 patents
  • METAGENOMI, INC.: 1 patents
• Recent patents:
  • 20250002881. CLASS II, TYPE V CRISPR SYSTEMS (Metagenomi, Inc.) (20250102)
  • 20250059568. CLASS II, TYPE V CRISPR SYSTEMS (METAGENOMI, INC.) (20250220)

Cindy CASTELLE of San Francisco CA (US)

• Number of Gene Editing patents: 2
• Top companies:
  • Metagenomi, Inc.: 1 patents
  • METAGENOMI, INC.: 1 patents
• Recent patents:
  • 20250002881. CLASS II, TYPE V CRISPR SYSTEMS (Metagenomi, Inc.) (20250102)
  • 20250059568. CLASS II, TYPE V CRISPR SYSTEMS (METAGENOMI, INC.) (20250220)

Lisa ALEXANDER of Albany CA (US)

• Number of Gene Editing patents: 2
• Top companies:
  • Metagenomi, Inc.: 1 patents
  • METAGENOMI, INC.: 1 patents
• Recent patents:
  • 20250002881. CLASS II, TYPE V CRISPR SYSTEMS (Metagenomi, Inc.) (20250102)
  • 20250059568. CLASS II, TYPE V CRISPR SYSTEMS (METAGENOMI, INC.) (20250220)

Tirtha Chakraborty of Cambridge MA (US)

• Number of Gene Editing patents: 2
• Top companies:
  • Vertex Pharmaceuticals Incorporated: 1 patents
  • VOR BIOPHARMA INC.: 1 patents
• Recent patents:
  • 20250041349. CRISPR-CAS9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells and Uses Thereof (Vertex Pharmaceuticals Incorporated) (20250206)
  • 20250140342. GENOTYPING CELLS USING SINGLE-CELL DNA SEQUENCING DATA (VOR BIOPHARMA INC.) (20250501)

James M. Wilson of Philadelphia PA (US)

• Number of Gene Editing patents: 2
• Top companies:
  • The Trustees of the University of Pennsylvania: 2 patents
• Recent patents:
  • 20250041445. GENE THERAPY FOR TREATMENT OF MUCOPOLYSACCHARIDOSIS IIIA (The Trustees of the University of Pennsylvania) (20250206)
  • 20250161493. COMPOSITIONS AND METHODS FOR IN VIVO NUCLEASE-MEDIATED TREATMENT OF ORNITHINE TRANSCARBAMYLASE (OTC) DEFICIENCY (The Trustees of the University of Pennsylvania) (20250522)

Top Collaborations in Gene Editing

Top US States for Gene Editing Inventors

Top Cities for Gene Editing Inventors

• Cambridge: 92 inventors
• Shenzhen: 63 inventors
• San Francisco: 48 inventors
• Shanghai: 40 inventors
• Durham: 36 inventors
• Seattle: 36 inventors
• Philadelphia: 30 inventors
• New York: 27 inventors
• San Diego: 27 inventors
• Pleasanton: 25 inventors
• Boston: 22 inventors
• La Jolla: 21 inventors
• Oakland: 21 inventors
• South Boston: 21 inventors
• Suwon-si: 20 inventors
• London: 19 inventors
• Wuxi: 16 inventors
• Beijing: 16 inventors
• Berkeley: 15 inventors
• Baltimore: 13 inventors